AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 168 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,048,469 | -14.3% | 134,938 | +6.7% | 0.00% | – |
| Q2 2023 | $1,223,813 | -11.9% | 126,427 | -0.2% | 0.00% | – |
| Q1 2023 | $1,388,752 | +289.3% | 126,711 | +53.4% | 0.00% | – |
| Q4 2022 | $356,758 | -46.4% | 82,583 | -6.6% | 0.00% | – |
| Q3 2022 | $665,000 | -23.4% | 88,451 | +2.3% | 0.00% | – |
| Q2 2022 | $868,000 | +114.3% | 86,466 | +164.0% | 0.00% | – |
| Q1 2022 | $405,000 | +55.2% | 32,751 | +187.0% | 0.00% | – |
| Q4 2021 | $261,000 | -19.4% | 11,411 | -22.0% | 0.00% | – |
| Q3 2021 | $324,000 | +39.1% | 14,629 | -18.6% | 0.00% | – |
| Q2 2021 | $233,000 | +385.4% | 17,971 | +69.9% | 0.00% | – |
| Q4 2017 | $48,000 | – | 10,578 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 111,608 | $2,470,000 | 3.15% |
| ACT CAPITAL MANAGEMENT, LLC | 180,000 | $3,983,000 | 2.06% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 167,889 | $3,715,000 | 1.92% |
| DG Capital Management, LLC | 402,200 | $8,901,000 | 1.81% |
| NEA Management Company, LLC | 5,172,683 | $114,471,000 | 1.36% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 801,100 | $17,728,000 | 0.99% |
| Altium Capital Management LP | 144,000 | $3,187,000 | 0.84% |
| HighMark Wealth Management LLC | 50,569 | $1,119,000 | 0.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 123,500 | $2,724,000 | 0.66% |
| SEVEN EIGHT CAPITAL, LP | 288,840 | $6,392,000 | 0.62% |